OBIO director gets RSUs, options; shares withheld for tax
Orchestra BioMed Holdings director David Pacitti reported compensation-related equity awards and a routine tax withholding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Orchestra BioMed Holdings director David Pacitti reported compensation-related equity awards and a routine tax withholding. On June 23, 2026, he received 17,327 restricted stock units, each representing one future share of common stock, and a stock option for 21,277 shares at an exercise price of $4.04 per share. Both the RSUs and options vest on the one-year anniversary of the grant date, contingent on his continued service. On June 24, 2026, 3,784 shares were withheld by the company to cover tax obligations upon RSU vesting, with no shares sold in the market. Following these transactions, he directly holds 58,511 common shares and holds options for 21,277 additional shares.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Pacitti David
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 3,784 | $0.00 | $0.00 |
| Grant/Award | Stock Option (Right to Buy) | 21,277 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.0001 per share ("Common Stock") | 17,327 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 21,277 contracts (Direct);
Common Stock, par value $0.0001 per share ("Common Stock") — 62,295 shares (Direct);
Common Stock — 58,511 shares (Direct)
Footnotes (3)
- F1. Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person on June 23, 2026 (the "Grant Date"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.
- F2. Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of RSUs. No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
- F3. The stock options will vest on the one year anniversary of the Grant Date, subject to the Reporting Person's continuous service through such date.
Key Figures
RSU grant: 17,327 units
Option grant size: 21,277 shares
Option exercise price: $4.04 per share
+4 more
7 metrics
RSU grant
17,327 units
Restricted stock units granted June 23, 2026; 1 share per unit
Option grant size
21,277 shares
Stock option covering common shares granted June 23, 2026
Option exercise price
$4.04 per share
Stock option exercise price for 21,277 underlying shares
Tax withholding shares
3,784 shares
Shares withheld June 24, 2026 to satisfy RSU tax obligations
Common shares after transactions
58,511 shares
Direct common stock holdings following tax withholding event
RSU vesting timing
1-year cliff
RSUs vest one year after June 23, 2026, subject to service
Option expiration
June 23, 2036
Expiration date of stock option granted June 23, 2026
Key Terms
restricted stock units, RSUs, tax withholding obligations, Stock Option (Right to Buy), +1 more
5 terms
restricted stock units financial
"Represents an award of restricted stock units ("RSUs") awarded to the Reporting Person"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Each RSU represents a contingent right to receive one share of Common Stock."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
tax withholding obligations financial
"Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of RSUs."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price": "4.0400""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did OBIO director David Pacitti report on this Form 4?
David Pacitti reported equity compensation grants and a tax-related share withholding. He received 17,327 restricted stock units and a stock option for 21,277 shares, and 3,784 shares were withheld to satisfy tax obligations related to RSU vesting, with no market sales involved.
How many Orchestra BioMed (OBIO) RSUs were granted to David Pacitti and when do they vest?
Pacitti was granted 17,327 restricted stock units on June 23, 2026. Each RSU converts into one share of common stock, vesting on the one-year anniversary of the grant date, subject to his continuous service with Orchestra BioMed through that vesting date.
What stock options did OBIO grant to David Pacitti and at what exercise price?
Orchestra BioMed granted Pacitti a stock option covering 21,277 shares of common stock at a $4.04 exercise price. The option was granted on June 23, 2026 and will fully vest one year after the grant date, contingent on his continued service with the company.
Are the OBIO insider transactions by David Pacitti open-market buys or sales?
The filing shows no open-market purchases or sales by Pacitti. The acquisitions are equity compensation grants of RSUs and options, while the disposition is a tax withholding event where 3,784 shares were retained by the company to satisfy tax obligations on RSU vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
